Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregers R Andersen

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Nucleic Acids Research|November 30, 2010
Synergistic activation of eIF4A by eIF4B and eIF4GKlaus H Nielsen, Manja A Behrens, Yangzi He, et al.
Biochimica Et Biophysica Acta|April 4, 2015
Multiple low-affinity interactions support binding of human osteopontin to integrin αXβ2Eva Kläning, Brian Christensen, Goran Bajic, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2017
Structure and activation of C1, the complex initiating the classical pathway of the complement cascadeSimon A Mortensen, Bjoern Sander, Rasmus K Jensen, et al.
The Journal of Biological Chemistry|June 7, 2021
Mutation-induced dimerization of transforming growth factor-β-induced protein may drive protein aggregation in granular corneal dystrophyNadia Sukusu Nielsen, Trine A F Gadeberg, Ebbe Toftgaard Poulsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2012
Structural basis for activation of the complement system by component C4 cleavageRune T Kidmose, Nick S Laursen, József Dobó, et al.
Frontiers in Immunology|December 18, 2018
A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the <i>Staphylococcus aureus</i> SSL7 ProteinLaure Yatime, Nicolas S Merle, Annette G Hansen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2023
Bispecific Complement Engagers for Targeted Complement ActivationDennis V Pedersen, Heidi Gytz, Mikael B L Winkler, et al.
The EMBO Journal|February 21, 2004
Domain movements of elongation factor eEF2 and the eukaryotic 80S ribosome facilitate tRNA translocationChristian M T Spahn, Maria G Gomez-Lorenzo, Robert A Grassucci, et al.
Nature Communications|May 31, 2022
Cryo-EM structures of human A2ML1 elucidate the protease-inhibitory mechanism of the A2M familyNadia Sukusu Nielsen, Alessandra Zarantonello, Seandean Lykke Harwood, et al.
Allergy|June 21, 2022
Structural and functional analyses of antibodies specific for modified core N-glycans suggest a role in T<sub>H</sub> 2 responsesMelanie Plum, Luna Tjerrild, Tim Raiber, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Nucleic Acids Research|November 30, 2010
Synergistic activation of eIF4A by eIF4B and eIF4GKlaus H Nielsen, Manja A Behrens, Yangzi He, et al.
Biochimica Et Biophysica Acta|April 4, 2015
Multiple low-affinity interactions support binding of human osteopontin to integrin αXβ2Eva Kläning, Brian Christensen, Goran Bajic, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2017
Structure and activation of C1, the complex initiating the classical pathway of the complement cascadeSimon A Mortensen, Bjoern Sander, Rasmus K Jensen, et al.
The Journal of Biological Chemistry|June 7, 2021
Mutation-induced dimerization of transforming growth factor-β-induced protein may drive protein aggregation in granular corneal dystrophyNadia Sukusu Nielsen, Trine A F Gadeberg, Ebbe Toftgaard Poulsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2012
Structural basis for activation of the complement system by component C4 cleavageRune T Kidmose, Nick S Laursen, József Dobó, et al.
Frontiers in Immunology|December 18, 2018
A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the <i>Staphylococcus aureus</i> SSL7 ProteinLaure Yatime, Nicolas S Merle, Annette G Hansen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2023
Bispecific Complement Engagers for Targeted Complement ActivationDennis V Pedersen, Heidi Gytz, Mikael B L Winkler, et al.
The EMBO Journal|February 21, 2004
Domain movements of elongation factor eEF2 and the eukaryotic 80S ribosome facilitate tRNA translocationChristian M T Spahn, Maria G Gomez-Lorenzo, Robert A Grassucci, et al.
Nature Communications|May 31, 2022
Cryo-EM structures of human A2ML1 elucidate the protease-inhibitory mechanism of the A2M familyNadia Sukusu Nielsen, Alessandra Zarantonello, Seandean Lykke Harwood, et al.
Allergy|June 21, 2022
Structural and functional analyses of antibodies specific for modified core N-glycans suggest a role in T<sub>H</sub> 2 responsesMelanie Plum, Luna Tjerrild, Tim Raiber, et al.
Pageof 8